Radiotherapy for oligometastatic disease in patients with spinal cord compression (MSCC) from relatively radioresistant tumors.
Standard
Radiotherapy for oligometastatic disease in patients with spinal cord compression (MSCC) from relatively radioresistant tumors. / Freundt, Katja; Meyners, Thekla; Bajrovic, Amira; Basic, Hiba; Karstens, Johann H; Adamietz, Irenaeus A; Rudat, Volker; Schild, Steven E; Dunst, Juergen; Rades, Dirk.
in: STRAHLENTHER ONKOL, Jahrgang 186, Nr. 4, 4, 2010, S. 218-223.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Radiotherapy for oligometastatic disease in patients with spinal cord compression (MSCC) from relatively radioresistant tumors.
AU - Freundt, Katja
AU - Meyners, Thekla
AU - Bajrovic, Amira
AU - Basic, Hiba
AU - Karstens, Johann H
AU - Adamietz, Irenaeus A
AU - Rudat, Volker
AU - Schild, Steven E
AU - Dunst, Juergen
AU - Rades, Dirk
PY - 2010
Y1 - 2010
N2 - Radiotherapy alone is the most common treatment for metastatic spinal cord compression (MSCC). Patients with relatively radioresistant tumors and oligometastatic disease may benefit from more intensive therapies (surgery, high-precision radiotherapy). If such therapies are not available, one can speculate whether patients benefit from dose escalation beyond the standard regimen 30 Gy in ten fractions.
AB - Radiotherapy alone is the most common treatment for metastatic spinal cord compression (MSCC). Patients with relatively radioresistant tumors and oligometastatic disease may benefit from more intensive therapies (surgery, high-precision radiotherapy). If such therapies are not available, one can speculate whether patients benefit from dose escalation beyond the standard regimen 30 Gy in ten fractions.
M3 - SCORING: Zeitschriftenaufsatz
VL - 186
SP - 218
EP - 223
JO - STRAHLENTHER ONKOL
JF - STRAHLENTHER ONKOL
SN - 0179-7158
IS - 4
M1 - 4
ER -